Table 1 Description of the study participants
From: Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy
ENP | EP | NNP | NP | |
|---|---|---|---|---|
N | 38 | 145 | 23 | 16 |
Age, years median (IQR) | 26 (20; 29) | 25 (18; 32) | 36 (29; 44) | 29 (26; 32) |
Sex (females), n (%) | 38 (100) | 145 (100) | 9 (39.1) | 16 (100) |
Plasmodium infection in peripheral blood, n (%) | 3 (7.69) | 20 (13.8) | na | na |
Gravidity, n (%) | na | Primigravida 53 (36.8) | na | nd |
1–3 pregnancies 30 (20.8) | ||||
4 + pregnancies 61 (42.4) | ||||
Sampling timepoint, n (%) | ||||
Recruitment (peripheral blood) | na | 54 (37.3) | na | 0 (0) |
Delivery (peripheral and placental blood) | na | 91 (62.7) | na | 16 (100) |
Gestational age by timepoint, weeks median (IQR) | ||||
Recruitment | na | 21 (12; 25) | na | nd |
Delivery | na | 39 (35; 43) | na | nd |